Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Sirtuin 5 aggravates microglia-induced neuroinflammation following ischaemic stroke by modulating the desuccinylation of Annexin-A1.

Tytuł:
Sirtuin 5 aggravates microglia-induced neuroinflammation following ischaemic stroke by modulating the desuccinylation of Annexin-A1.
Autorzy:
Xia Q; Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Gao S; Department of Neurosurgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China.
Han T; Department of Neurosurgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China.
Mao M; Department of Anesthesiology and Perioperative Medicine, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, China.
Zhan G; Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Wang Y; Department of Neurosurgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China. .
Li X; Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. .
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2022 Dec 14; Vol. 19 (1), pp. 301. Date of Electronic Publication: 2022 Dec 14.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: [London] : BioMed Central, c2004-
MeSH Terms:
Annexin A1*/genetics
Annexin A1*/metabolism
Brain Ischemia*/genetics
Brain Ischemia*/metabolism
Ischemic Stroke*/genetics
Ischemic Stroke*/metabolism
Sirtuins*/genetics
Sirtuins*/metabolism
Animals ; Mice ; Brain Injuries/genetics ; Brain Injuries/metabolism ; Infarction, Middle Cerebral Artery/complications ; Microglia/metabolism ; Neuroinflammatory Diseases ; Stroke/genetics ; Stroke/metabolism
References:
Cell. 2014 Nov 6;159(4):956-956.e1. (PMID: 25417168)
Cell Cycle. 2022 May;21(10):1020-1033. (PMID: 35230909)
Cell Signal. 2013 Oct;25(10):1962-9. (PMID: 23727357)
Circulation. 2017 Feb 21;135(8):759-771. (PMID: 28052979)
Cell Rep. 2013 Aug 29;4(4):842-51. (PMID: 23954790)
Brain. 2021 Jun 22;144(5):1526-1541. (PMID: 34148071)
Blood. 2021 Mar 18;137(11):1538-1549. (PMID: 33512489)
Am J Cancer Res. 2021 Oct 15;11(10):4683-4699. (PMID: 34765287)
Neuron. 2019 Jan 16;101(2):207-223.e10. (PMID: 30606613)
Crit Rev Biochem Mol Biol. 2018 Jun;53(3):311-334. (PMID: 29637793)
Int J Cardiol. 2018 Jun 1;260:148-155. (PMID: 29622432)
Science. 2011 Nov 11;334(6057):806-9. (PMID: 22076378)
Neurochem Res. 2019 Oct;44(10):2346-2359. (PMID: 30903449)
Immunity. 2013 Jan 24;38(1):79-91. (PMID: 23273845)
Cell Death Differ. 2019 Jan;26(2):260-275. (PMID: 29769639)
Eur J Pharmacol. 2018 Jan 5;818:410-418. (PMID: 29154835)
AACN Clin Issues. 2005 Oct-Dec;16(4):421-40; quiz 597-8. (PMID: 16269890)
Cell Death Differ. 2022 Apr;29(4):722-736. (PMID: 34642466)
Exp Mol Med. 2022 Feb;54(2):180-193. (PMID: 35217833)
Acta Pharmacol Sin. 2017 Apr;38(4):445-458. (PMID: 28260801)
J Neuroimmunol. 2014 Nov 15;276(1-2):24-36. (PMID: 25115219)
Elife. 2022 Mar 16;11:. (PMID: 35293862)
Nat Rev Dis Primers. 2019 Oct 10;5(1):70. (PMID: 31601801)
Cell Signal. 2014 Jan;26(1):173-8. (PMID: 24103589)
Nature. 2009 Jul 30;460(7255):587-91. (PMID: 19641587)
Brain Sci. 2020 Mar 11;10(3):. (PMID: 32168831)
Stroke. 2021 Dec;52(12):4043-4053. (PMID: 34807744)
Front Cell Neurosci. 2021 Jul 01;15:683769. (PMID: 34276309)
Cell Rep. 2017 Jun 13;19(11):2331-2344. (PMID: 28614718)
Adv Sci (Weinh). 2021 Sep;8(18):e2100881. (PMID: 34319001)
J Mol Cell Cardiol. 2020 Jan;138:49-58. (PMID: 31751566)
Nat Chem Biol. 2011 Jan;7(1):58-63. (PMID: 21151122)
Sci Adv. 2021 Jan 20;7(4):. (PMID: 33523920)
Theranostics. 2021 Jun 1;11(15):7450-7470. (PMID: 34158860)
Prog Neurobiol. 2016 Jul;142:23-44. (PMID: 27166859)
Neuron. 2022 Nov 2;110(21):3458-3483. (PMID: 36327895)
Clin Transl Med. 2020 Sep;10(5):e172. (PMID: 32997407)
Mol Med Rep. 2020 May;21(5):2006-2018. (PMID: 32323760)
Cell Death Dis. 2018 May 29;9(6):657. (PMID: 29844306)
Mol Neurobiol. 2015 Apr;51(2):729-42. (PMID: 24939696)
Mol Cell. 2013 Jun 27;50(6):919-30. (PMID: 23806337)
Mol Biosyst. 2016 Mar;12(3):786-95. (PMID: 26739209)
Sci Rep. 2016 Jul 18;6:27028. (PMID: 27426034)
J Cereb Blood Flow Metab. 2017 Nov;37(11):3488-3517. (PMID: 28797196)
Cell Rep. 2018 Oct 23;25(4):934-946.e5. (PMID: 30355499)
Neuron. 2018 Aug 8;99(3):464-479.e7. (PMID: 30033154)
Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1350-1358. (PMID: 28389361)
Cell Death Dis. 2016 Sep 01;7(9):e2356. (PMID: 27584794)
Am J Physiol Cell Physiol. 2018 Feb 1;314(2):C228-C232. (PMID: 29167150)
Int J Mol Sci. 2021 Jun 04;22(11):. (PMID: 34199982)
J Cell Mol Med. 2021 Aug;25(15):7101-7109. (PMID: 34160884)
Trends Plant Sci. 2018 Dec;23(12):1068-1080. (PMID: 30279071)
Biomed Pharmacother. 2018 Sep;105:518-525. (PMID: 29883947)
PLoS Biol. 2020 Jul 14;18(7):e3000410. (PMID: 32663219)
Biochem Pharmacol. 2009 Jun 15;77(12):1814-26. (PMID: 19428336)
Genes Dis. 2019 Oct 08;7(2):166-171. (PMID: 32215286)
Circulation. 2021 Feb 23;143(8):e254-e743. (PMID: 33501848)
FASEB J. 2006 Jul;20(9):1498-500. (PMID: 16720734)
Grant Information:
201601D011104 General Natural Fund Project of Department of Science and Technology of Shanxi Province; 31800896 National Natural Science Foundation of China; 2020YQ17 Tongji Hospital (HUST) Foundation for Excellent Young Scientist
Contributed Indexing:
Keywords: Annexin A1; Cerebral ischaemia and reperfusion injury; Microglia; Neuroinflammation; Sirtuin 5; Succinylation
Substance Nomenclature:
0 (Annexin A1)
0 (annexin A1, mouse)
0 (SIRT5 protein, mouse)
EC 3.5.1.- (Sirtuins)
Entry Date(s):
Date Created: 20221214 Date Completed: 20230104 Latest Revision: 20230104
Update Code:
20240105
PubMed Central ID:
PMC9753274
DOI:
10.1186/s12974-022-02665-x
PMID:
36517900
Czasopismo naukowe
Background: Microglia-induced excessive neuroinflammation plays a crucial role in the pathophysiology of multiple neurological diseases, such as ischaemic stroke. Controlling inflammatory responses is considered a promising therapeutic approach. Sirtuin 5 (SIRT5) mediates lysine desuccinylation, which is involved in various critical biological processes, but its role in ischaemic stroke remains poorly understood. This research systematically explored the function and potential mechanism of SIRT5 in microglia-induced neuroinflammation in ischaemic stroke.
Methods: Mice subjected to middle cerebral artery occlusion were established as the animal model, and primary cultured microglia treated with oxygen-glucose deprivation and reperfusion were established as the cell model of ischaemic stroke. SIRT5 short hairpin RNA, adenovirus and adeno-associated virus techniques were employed to modulate SIRT5 expression in microglia both in vitro and in vivo. Coimmunoprecipitation, western blot and quantitative real-time PCR assays were performed to reveal the molecular mechanism.
Results: In the current study, we showed that SIRT5 expression in microglia was increased in the early phase of ischaemic stroke. SIRT5 interacts with and desuccinylates Annexin A1 (ANXA1) at K166, which in turn decreases its SUMOylation level. Notably, the desuccinylation of ANXA1 blocks its membrane recruitment and extracellular secretion, resulting in the hyperactivation of microglia and excessive expression of proinflammatory cytokines and chemokines, ultimately leading to neuronal cell damage after ischaemic stroke. Further investigation showed that microglia-specific forced overexpression of SIRT5 worsened ischaemic brain injury, whereas downregulation of SIRT5 exhibited neuroprotective and cognitive-preserving effects against ischaemic brain injury, as proven by the decreased infarct area, reduced neurological deficit scores, and improved cognitive function.
Conclusions: Collectively, these data identify SIRT5 as a novel regulator of microglia-induced neuroinflammation and neuronal damage after cerebral ischaemia. Interventions targeting SIRT5 expression may represent a potential therapeutic target for ischaemic stroke.
(© 2022. The Author(s).)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies